OPTN

OptiNose (OPTN)

OptiNose Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OPTN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/19	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/08	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/08	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/08	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/08	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc
2024/06/07	05 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/05/30	04 : 32	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OPTN	OptiNose Inc
2024/05/21	05 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/05/21	03 : 33	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:OPTN	OptiNose Inc
2024/05/18	01 : 00	GlobeNewswire Inc.	Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	NASDAQ:OPTN	OptiNose Inc
2024/05/14	22 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OPTN	OptiNose Inc
2024/05/14	20 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/05/14	20 : 00	GlobeNewswire Inc.	Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights	NASDAQ:OPTN	OptiNose Inc
2024/05/11	03 : 56	GlobeNewswire Inc.	Optinose Announces Reporting Date for First Quarter 2024 Financial Results	NASDAQ:OPTN	OptiNose Inc
2024/05/09	20 : 09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OPTN	OptiNose Inc
2024/05/09	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/05/09	20 : 03	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OPTN	OptiNose Inc
2024/05/09	20 : 02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OPTN	OptiNose Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	Optinose Announces $55 Million Registered Direct Offering	NASDAQ:OPTN	OptiNose Inc
2024/04/25	20 : 00	GlobeNewswire Inc.	Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million	NASDAQ:OPTN	OptiNose Inc
2024/04/05	05 : 01	GlobeNewswire Inc.	Optinose to Present at the Needham Virtual Healthcare Conference	NASDAQ:OPTN	OptiNose Inc
2024/03/16	04 : 34	GlobeNewswire Inc.	XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps	NASDAQ:OPTN	OptiNose Inc
2024/03/09	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/03/08	06 : 32	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OPTN	OptiNose Inc
2024/03/07	21 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OPTN	OptiNose Inc
2024/03/07	21 : 00	GlobeNewswire Inc.	Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights	NASDAQ:OPTN	OptiNose Inc
2024/03/07	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPTN	OptiNose Inc
2024/03/01	06 : 40	GlobeNewswire Inc.	Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results	NASDAQ:OPTN	OptiNose Inc
2024/03/01	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPTN	OptiNose Inc